Paper42958367PubMed
CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer.
Liu Y and 9 others. Mol Cancer, 2026.
Cite this record
ConductScience Library. CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer. Papers, record 42958367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42958367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CRAT-mediated acetylcarnitine shuttling sustains p65 acetylation and NF-κB-associated radioresistance in colorectal cancer.
- Journal
- Mol Cancer
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-31
Source PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Radiation Tolerance | Major topic |
| Colorectal Neoplasms | Major topic |
| Acetylcarnitine | Major topic |
| Transcription Factor RelA | Major topic |
| NF-kappa B | Major topic |
| Humans | |
| Acetylation | |
| Animals | |
| Mice | |
| Cell Line, Tumor | |
| Xenograft Model Antitumor Assays | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2024Y9615 | Joint Funds for the innovation of science and Technology, Fujian province | PubMed | ||
| 2024Y9611 | Joint Funds for the innovation of science and Technology, Fujian province | PubMed | ||
| 2021Y9225 | Joint Funds for the innovation of science and Technology, Fujian province | PubMed | ||
| 2023Y9450 | Joint Funds for the innovation of science and Technology, Fujian province | PubMed | ||
| 2021Y9202 | Joint Funds for the innovation of science and Technology, Fujian province | PubMed | ||
| F2227R-LJ01-01 | Fujian Research and Training Grants for Youth and Middle-aged Leaders in Healthcare (2022) | PubMed |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34395263 | A Genome-Scale CRISPR Knock-Out Screen Identifies MicroRNA-5197-5p as a Promising Radiosensitive Biomarker in Colorectal Cancer. | Front Oncol | 2021 | https://conductscience.org/library/papers/34395263 | PubMed |
| 2 | 38445632 | Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review. | Cancer Biol Ther | 2024 | https://conductscience.org/library/papers/38445632 | PubMed |
| 3 | 26122185 | Opportunities and challenges of radiotherapy for treating cancer. | Nat Rev Clin Oncol | 2015 | https://conductscience.org/library/papers/26122185 | PubMed |
| 4 | 12456660 | Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. | EMBO J | 2002 | https://conductscience.org/library/papers/12456660 | PubMed |
| 5 | 35798917 | Acetyl-CoA synthetase 2(ACSS2): a review with a focus on metabolism and tumor development. | Discov Oncol | 2022 | https://conductscience.org/library/papers/35798917 | PubMed |
| 6 | 22257950 | The diverse and complex roles of NF-κB subunits in cancer. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22257950 | PubMed |
| 7 | 39528460 | Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts. | Nat Commun | 2024 | https://conductscience.org/library/papers/39528460 | PubMed |
| 8 | 26039447 | Acetyl coenzyme A: a central metabolite and second messenger. | Cell Metab | 2015 | https://conductscience.org/library/papers/26039447 | PubMed |
| 9 | 20692872 | Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data. | Lancet Oncol | 2010 | https://conductscience.org/library/papers/20692872 | PubMed |
| 10 | 24998913 | Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. | Cell Metab | 2014 | https://conductscience.org/library/papers/24998913 | PubMed |
| 11 | 33543577 | College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer. | Oncologist | 2021 | https://conductscience.org/library/papers/33543577 | PubMed |
| 12 | 39828731 | CRAT downregulation promotes ovarian cancer progression by facilitating mitochondrial metabolism through decreasing the acetylation of PGC-1α. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/39828731 | PubMed |
| 13 | 25929862 | The Accomplices of NF-κB Lead to Radioresistance. | Curr Protein Pept Sci | 2015 | https://conductscience.org/library/papers/25929862 | PubMed |
| 14 | 29741565 | Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2018 | https://conductscience.org/library/papers/29741565 | PubMed |
| 15 | 38433280 | NF-κB in biology and targeted therapy: new insights and translational implications. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38433280 | PubMed |
| 16 | 36658431 | Acetyl-CoA metabolism in cancer. | Nat Rev Cancer | 2023 | https://conductscience.org/library/papers/36658431 | PubMed |
| 17 | 37322433 | Molecular mechanisms of tumor resistance to radiotherapy. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37322433 | PubMed |
| 18 | 17967430 | NF-kappa B-mediated adaptive resistance to ionizing radiation. | Free Radic Biol Med | 2008 | https://conductscience.org/library/papers/17967430 | PubMed |
| 19 | 39457381 | Molecular Mechanism of Radioresponsiveness in Colorectal Cancer: A Systematic Review. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/39457381 | PubMed |
| 20 | 39014491 | Versatile function of NF-ĸB in inflammation and cancer. | Exp Hematol Oncol | 2024 | https://conductscience.org/library/papers/39014491 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42958367
GET https://conductscience.org/api/papers/v1/42958367/references?page=2